Status:

COMPLETED

Pathways for Health Equity Quality Improvement Strategy

Lead Sponsor:

Western University, Canada

Collaborating Sponsors:

Canadian Institutes of Health Research (CIHR)

AstraZeneca

Conditions:

Diabetes Mellitus Type 2 With Hyperglycemia

Eligibility:

All Genders

18+ years

Brief Summary

The PATHWAYS for Health Equity research program builds on the 5-year FORGE AHEAD Indigenous diabetes quality improvement research program (2013 - 2017). PATHWAYS for Health Equity, a 3-year research ...

Detailed Description

GOAL To improve the health and health equity of Indigenous peoples by strengthening the effectiveness, sustainability and scalability of a promising community-driven and culturally-relevant quality i...

Eligibility Criteria

Inclusion

  • Indigenous Communities in Canada:
  • On-reserve community
  • Community Band Council approval to participate and collaboration
  • Community healthcare facility approval or willingness to participate including both prevention and management/treatment arms if separate
  • Signed Community Research Agreement (including Financial Agreement) by the custodian of community medical charts, health leadership, and community leadership (if required). Access to community medical charts is required for FNDSS
  • Patient Chart Inclusion Criteria for chart audit component:
  • Age 18 or older.
  • Diagnosed with type 2 diabetes

Exclusion

  • Indigenous Communities:
  • Communities that are unlikely to comply with the protocol (uncooperative attitude, unlikelihood of completing the program)
  • Healthcare facility unwilling to participate or uncooperative.
  • Patient Chart Exclusion Criteria for chart audit component:
  • Less than 18 years old
  • Diagnosed with type 1 or gestational diabetes
  • Life expectancy is less than 6 months
  • Inactive patient (no clinic visit in the last 12 months)

Key Trial Info

Start Date :

October 26 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 31 2022

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT03315728

Start Date

October 26 2017

End Date

March 31 2022

Last Update

April 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Western University

London, Ontario, Canada, N6C 4Z9